CDT Equity (CDT) Receivables - Other (2022 - 2025)
CDT Equity's (CDT) quarterly Receivables - Other came in at $245000.0 in Q2 2025, up 30.32% YoY from $188000.0 in Q2 2024, and down 49.8% on a QoQ basis from $488000.0 in Q1 2025.
CDT Equity (CDT) Receivables - Other (2022 - 2025) Analysis & Trends
CDT Equity (CDT) has 4 years of Receivables - Other data on file, last reported at $245000.0 in Q2 2025.
- Quarterly Receivables - Other rose 30.32% year-over-year to $245000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $245000.0 (up 30.32% YoY) and the FY2024 annual result came in at $489000.0, changed N/A from the prior year.
- Receivables - Other eased to $245000.0 in Q2 2025, from $488000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $500000.0 in Q3 2024 to a low of $100000.0 in Q3 2023.
- A 4-year average of $330000.0 and a median of $300000.0 in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2024 — Receivables - Other soared 400.0% — and 2025, when it surged 30.32%.
- Tracing CDT's Receivables - Other over 4 years: stood at $300000.0 in 2022, then slumped by 66.67% to $100000.0 in 2023, then jumped by 389.0% to $489000.0 in 2024, then slumped by 49.9% to $245000.0 in 2025.
- The last three Receivables - Other figures came in at $245000.0 (Q2 2025), $488000.0 (Q1 2025), and $489000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 245,000.00 |
| Jun 30, 2025 | 245,000.00 |
| Mar 31, 2025 | 488,000.00 |
| Mar 31, 2025 | 488,000.00 |
| Dec 31, 2024 | 489,000.00 |
| Dec 31, 2024 | 489,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Dec 31, 2022 | 300,000.00 |